↓ Expand ↓
» About This Blog

Qteros Regroups

Last Friday, press reports began to circulate that cellulosic ethanol start-up Qteros had fired its CEO John McCarthy, laid off a bunch of staff, and may be for sale. I was intrigued as I had written a bit about the company in the past, and realized, in retrospect, that I hadn’t heard much about it lately.

In fact, it appears that Qteros is in a bit of a huddle and may change the scope of its future plans. I asked the new CEO, Mick Sawka, formerly the company’s senior vice president of engineering and commercial development if he could update me. By e-mail he replied that “Qteros has reduced its staff and John McCarthy has stepped down as CEO. … Based on our data and that of our strategic partner, Praj Industries, we remain confident that we have one of the best process and economic routes to cellulosic ethanol production. Under our new leadership we continue to develop our process.”

Praj Industries is an Indian firm focused on engineering for biobased ethanol. It wants to expand into cellulosic feedstocks.

The partnership was announced early in January, just a day before the firm disclosed it had raised $22 million in the first part of a C round of venture capital funding. At that time, the firm implied it planned to get more investments and proceed to commercialization. It sounds like the scope of the firm’s plans may have narrowed a bit. Cleantech Chemistry will keep an ear out for more information.

I wrote about Qteros’ former CEO John McCarthy back in February of 2010, when he had just taken the helm. Two other firms, Mascoma (also in cellulosic ethanol) and Segetis (in bio-based chemicals) had brand new CEOs at the same time. In all three cases, the new CEO’s were experienced hands who were brought in to guide the biobased firms to commercialization.

Qteros is not the only one of the three that has been quiet this year. Segetis’ most recent press release came out Feb. 14 and is about a deal with Method (a household cleaner firm) to develop a tub and tile cleaner made from bio-based molecules. Meanwhile, in September, Mascoma filed for an IPO worth up to $100 million – though it has not yet begun selling stock. Both firms have the same CEOs as they did when I wrote about them in 2010 –  Atul Thakrar is at Segetis and William J. Brady is still in charge at Mascoma.

 

No Comments

Leave a Reply


9 + eight =